Although Pgc1α overexpression did not protect mitochondrial health or muscle mass during cancer-induced cachexia, our in vitro data suggest the potential viability of mitochondria targeted therapeutics and suggest the need to further explore potential approaches therein. This evidence concerns the gene PPARGC1A and cancer.